Back to Search Start Over

Integrated multimodal cell atlas of Alzheimer's disease.

Authors :
Gabitto MI
Travaglini KJ
Rachleff VM
Kaplan ES
Long B
Ariza J
Ding Y
Mahoney JT
Dee N
Goldy J
Melief EJ
Agrawal A
Kana O
Zhen X
Barlow ST
Brouner K
Campos J
Campos J
Carr AJ
Casper T
Chakrabarty R
Clark M
Cool J
Dalley R
Darvas M
Ding SL
Dolbeare T
Egdorf T
Esposito L
Ferrer R
Fleckenstein LE
Gala R
Gary A
Gelfand E
Gloe J
Guilford N
Guzman J
Hirschstein D
Ho W
Hupp M
Jarsky T
Johansen N
Kalmbach BE
Keene LM
Khawand S
Kilgore MD
Kirkland A
Kunst M
Lee BR
Leytze M
Mac Donald CL
Malone J
Maltzer Z
Martin N
McCue R
McMillen D
Mena G
Meyerdierks E
Meyers KP
Mollenkopf T
Montine M
Nolan AL
Nyhus JK
Olsen PA
Pacleb M
Pagan CM
Peña N
Pham T
Pom CA
Postupna N
Rimorin C
Ruiz A
Saldi GA
Schantz AM
Shapovalova NV
Sorensen SA
Staats B
Sullivan M
Sunkin SM
Thompson C
Tieu M
Ting JT
Torkelson A
Tran T
Valera Cuevas NJ
Walling-Bell S
Wang MQ
Waters J
Wilson AM
Xiao M
Haynor D
Gatto NM
Jayadev S
Mufti S
Ng L
Mukherjee S
Crane PK
Latimer CS
Levi BP
Smith KA
Close JL
Miller JA
Hodge RD
Larson EB
Grabowski TJ
Hawrylycz M
Keene CD
Lein ES
Source :
Nature neuroscience [Nat Neurosci] 2024 Oct 14. Date of Electronic Publication: 2024 Oct 14.
Publication Year :
2024
Publisher :
Ahead of Print

Abstract

Alzheimer's disease (AD) is the leading cause of dementia in older adults. Although AD progression is characterized by stereotyped accumulation of proteinopathies, the affected cellular populations remain understudied. Here we use multiomics, spatial genomics and reference atlases from the BRAIN Initiative to study middle temporal gyrus cell types in 84 donors with varying AD pathologies. This cohort includes 33 male donors and 51 female donors, with an average age at time of death of 88 years. We used quantitative neuropathology to place donors along a disease pseudoprogression score. Pseudoprogression analysis revealed two disease phases: an early phase with a slow increase in pathology, presence of inflammatory microglia, reactive astrocytes, loss of somatostatin <superscript>+</superscript> inhibitory neurons, and a remyelination response by oligodendrocyte precursor cells; and a later phase with exponential increase in pathology, loss of excitatory neurons and Pvalb <superscript>+</superscript> and Vip <superscript>+</superscript> inhibitory neuron subtypes. These findings were replicated in other major AD studies.<br /> (© 2024. The Author(s).)

Details

Language :
English
ISSN :
1546-1726
Database :
MEDLINE
Journal :
Nature neuroscience
Publication Type :
Academic Journal
Accession number :
39402379
Full Text :
https://doi.org/10.1038/s41593-024-01774-5